Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 504563, 10 pages
http://dx.doi.org/10.1155/2013/504563
Research Article

A Laboratory Evaluation of Medicinal Herbs Used in China for the Treatment of Hand, Foot, and Mouth Disease

1Medical School and Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, 22 Hankou Road, Nanjing 210093, China
2State Key Laboratory of Pharmaceutical Biotechnology and School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China
3Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA
4Nanjing Children's Hospital, Nanjing Medical University, 72 Guangzhou Road, Nanjing 210008, China

Received 18 December 2012; Revised 5 February 2013; Accepted 7 February 2013

Academic Editor: Wen Chuan Lin

Copyright © 2013 Xiaoqing Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Yang, L. Ren, Z. Xiong et al., “Enterovirus 71 outbreak in the People's Republic of China in 2008,” Journal of Clinical Microbiology, vol. 47, no. 7, pp. 2351–2352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. WHO, Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China. 2008, http://www2.wpro.who.int/NR/rdonlyres/591D6A7B-FB15-4E94-A1E9-1D3381847D60/0/HFMDCCDC20080515ENG.pdf.
  3. H. Tian, Q. Z. Yang, J. Liang et al., “Clinical features and management outcomes of severe hand, foot and mouth disease,” Medical Principles and Practice, vol. 21, no. 4, pp. 355–359, 2012. View at Publisher · View at Google Scholar
  4. M. H. Ooi, S. C. Wong, P. Lewthwaite, M. J. Cardosa, and T. Solomon, “Clinical features, diagnosis, and management of enterovirus 71,” The Lancet Neurology, vol. 9, no. 11, pp. 1097–1105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ma, C. Fung, S. H. L. Yip, C. Wong, S. K. Chuang, and T. Tsang, “Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks,” The Pediatric Infectious Disease Journal, vol. 30, no. 8, pp. 675–679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Solomon, P. Lewthwaite, D. Perera, M. J. Cardosa, P. McMinn, and M. H. Ooi, “Virology, epidemiology, pathogenesis, and control of enterovirus 71,” The Lancet Infectious Diseases, vol. 10, no. 11, pp. 778–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. J. Cao, Z. L. Liu, P. Steinmann et al., “Chinese herbal medicines for treatment of hand, foot and mouth disease: a systematic review of randomized clinical trials,” European Journal of Integrative Medicine, vol. 4, no. 1, pp. e85–e111, 2012. View at Publisher · View at Google Scholar
  8. G. L. Zhang, Z. G. Li, J. B. Tong et al., “A review of Chinese traditional prescriptions used in treatment and prevention of hand, foot and mouth disease,” Clinical Journal of Traditional Chinese Medicine, vol. 22, no. 7, pp. 574–582, 2010. View at Google Scholar
  9. B. Xue, Z. Yao, and R. Yu, “Studies on anti-EV71 virus activity of traditional Chinese medicine and its clinical application in treatment of HFMD,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 23, pp. 3366–3370, 2011. View at Google Scholar
  10. T. Hozumi, T. Matsumoto, H. Ooyama et al., “Antiviral agent containing crude drug,” U.S. Patent 5,411,733, 1995.
  11. Y. Zhang, Z. Zhu, W. Yang et al., “An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China,” Virology Journal, vol. 7, no. 1, article 94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. J. Reed and H. Muench, “A simple method of estimating fifty per cent endpoints,” American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938. View at Google Scholar · View at Scopus
  13. C. C. Liu, A. H. Chou, S. P. Lien et al., “Identification and characterization of a cross-neutralization epitope of Enterovirus 71,” Vaccine, vol. 29, no. 26, pp. 4362–4372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Dulbecco and M. Vogt, “Plaque formation and isolation of pure lines with poliomyelitis viruses,” Journal of Experimental Medicine, vol. 99, no. 2, pp. 167–182, 1954. View at Publisher · View at Google Scholar
  15. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  16. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C. W. Lin, F. J. Tsai, C. H. Tsai et al., “Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds,” Antiviral Research, vol. 68, no. 1, pp. 36–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. C. Ma, J. Du, P. P. H. But et al., “Antiviral Chinese medicinal herbs against respiratory syncytial virus,” Journal of Ethnopharmacology, vol. 79, no. 2, pp. 205–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr, “Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus,” The Lancet, vol. 361, no. 9374, pp. 2045–2046, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Chang, Y. C. Chang, K. Z. Lu et al., “Antiviral activity of Isatis indigotica extract and its derived indirubin against Japanese encephalitis virus,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 925830, 7 pages, 2012. View at Publisher · View at Google Scholar
  21. T. Y. Lin, Y. C. Liu, J. R. Jheng et al., “Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities,” The American Journal of Chinese Medicine, vol. 37, no. 1, pp. 143–158, 2009. View at Google Scholar · View at Scopus
  22. K. K. Kuo, J. S. Chang, K. C. Wang, and L. C. Chiang, “Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line,” The American Journal of Chinese Medicine, vol. 37, no. 2, pp. 383–394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. F. J. Tsai, C. W. Lin, C. C. Lai et al., “Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins,” Food Chemistry, vol. 128, no. 2, pp. 312–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. C. Zhu, Y. Wang, Y. P. Liu et al., “Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin,” European Journal of Pharmaceutical Sciences, vol. 44, no. 3, pp. 392–398, 2011. View at Publisher · View at Google Scholar
  25. X. Chen, Z. Wang, Z. Yang et al., “Houttuynia cordata blocks HSV infection through inhibition of NF-kappaB activation,” Antiviral Research, vol. 92, no. 2, pp. 341–345, 2011. View at Publisher · View at Google Scholar
  26. T. Y. Lin, S. H. Hsia, Y. C. Huang, C. T. Wu, and L. Y. Chang, “Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system,” Clinical Infectious Diseases, vol. 36, no. 3, pp. 269–274, 2003. View at Publisher · View at Google Scholar · View at Scopus